Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases

17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases

US Patent 8546392 · Granted Oct 1, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PqsR inverse agonists2024
PQSR modulators2019
Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 22018
Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 22018
Indoline compounds as aldosterone synthase inhibitors2017
Indoline compounds as aldosterone synthase inhibitors2017
Catechol O-methyltransferase activity inhibiting compounds2016
Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases2016
Aldosterone synthase inhibitors2016
Selective inhibitors of human corticosteroid synthases2016
Aldosterone synthase inhibitors2015
6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds a2014